AMRX FY 2022 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMRXAmneal Pharmaceuticals, Inc.

$4B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.2B+5.7% YoY

Gross Profit

$791M35.8% margin

Operating Income

-$95M-4.3% margin

Net Income

-$130M-5.9% margin

EPS (Diluted)

$-0.86

Cash Flow

Operating Cash Flow

$65M

Free Cash Flow

-$25M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$3.8B

Total Liabilities

$3.6B

Stockholders' Equity

$298M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.2B	$2.1B	+5.7%
Gross Profit	$791M	$769M	+2.9%
Operating Income	-$95M	$153M	-162.2%
Net Income	-$130M	$11M	-1323.5%